Nathan Treff

Preimplantation genetic testing for polygenic disease risk (PGT-P) at Session 2 on Thursday 11th April

Dr. Treff received his PhD in Biochemistry from Washington State University in 2003 and performed postdoctoral fellowships in embryonic stem cell biology at the University of Wisconsin-Madison in 2004 and reproductive genetics at EMD Serono in 2005.  He previously served as a Research Director at RMA of New Jersey for over 10 years. He is currently Board Certified (ABB) in Molecular Diagnostics as a High Complexity Laboratory Director, a cofounder and the CSO and Clinical Laboratory Director of Genomic Prediction, and an Associate Professor at Rutgers University. He also serves as a Senior Editor of Fertility and Sterility Science and JARG, has published over 120 peer reviewed papers in reproductive genetics, and has received 7 awards from the ASRM.  His research on PGT has been reported on by the Wall Street Journal, New York Times, Forbes, Bloomberg, and the Economist, among other media outlets.